Venture Capital

Inflection Point Ventures

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage

Geographical Focus
India

Industries Focus

  • Financial Services
  • Technology
  • Healthcare
  • Energy
  • Consumer Goods
  • Real Estate
  • Telecommunications
  • Media
  • Automotive
  • Education
  • Agriculture
  • EdTech
  • FinTech
  • E-commerce
  • Logistics
  • Food and Beverage
  • Manufacturing
  • Entertainment
  • Clean Tech
  • Media and Entertainment
  • Travel and Hospitality

Investment Size:
100,000 to 1,000,000 USD

Investor Details Founded: 2018

Inflection Point Ventures (IPV) is a prominent Indian angel investment platform that specializes in early-stage investments in technology-driven companies. The firm has a strong track record, having invested over ₹750 crore out of its ₹1,200 crore fund, with plans to invest an additional ₹150-200 crore in startups this year. IPV evaluates more than 8,000 deals annually, aiming to back startups that address meaningful problems and have the potential for strong returns.

In 2023, IPV made 56 investments, comprising 46 new investments and around 10 follow-on investments. The firm also announced partial and full exits from 14 firms, achieving an average internal rate of return of 61%. Notably, IPV fully exited three startups in 2023, including Koovers, Sportido, and a media startup, with the highest return exceeding 200% from a full exit in the media venture.

In July 2025, IPV launched IPV International, a $110 million Category I Angel Fund registered under the International Financial Services Centres Authority (IFSCA) framework at GIFT City. The fund aims to invest in early-stage startups globally, with average ticket sizes ranging from $100,000 to $1 million. The first close of the fund took place in April 2025, and it has already made its debut investment in Singapore-based deeptech startup Cellivate Technologies, which is developing a patented, ethical, and scalable alternative to fetal bovine serum using magnetic stimulation, targeting applications in biotechnology and pharmaceuticals.

Requirements
  • Innovative business models
  • Scalable growth potential
  • Strong management teams
  • Clear market differentiation
  • Ability to achieve product-market fit
  • Technology-driven startups
  • Early-stage companies
  • High-growth potential
  • Innovative solutions addressing market needs
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

Portfolio Companies
  • BharatPe
  • Vedantu
  • Licious
  • MyPickup
  • SnapE Cabs
  • Edgehax
  • Fastest Healthtech
  • Koovers
  • Sportido
  • Cellivate Technologies
  • Oorja
  • Aerem
  • Devnagri
  • Ishitva
  • Kazam
  • Mindler
  • Bored Beverages
  • Clensta
  • Reloy
Claim this Investor

Are you an official representative of Inflection Point Ventures?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim